Home Management Tips for Acute or Chronic Lower Back Pain


 (DGIwire) – Some people bend over the wrong way while picking up a heavy box in their basement. Or maybe they have to deal with a chronic degenerative condition such as arthritis or a slipped disc that never healed properly. Regardless of the cause, lower back pain can be excruciating. It can also be very difficult to treat, and almost everyone can expect to experience it at some point in their lives.

With that in mind, WebMD offers the following tips for managing lower back pain at home:

  1. Chill it. Ice is best in the first 24 to 48 hours after an injury because it reduces inflammation. Whatever is used, take it off after about 20 minutes to give the skin a rest. If pain persists, talk with a doctor.
  2. Keep moving. Maintaining normal routines such as making the beds, going to work and walking the dog are all essential to recovery once one is feeling strong enough.
  3. Stretch. Get up every 20 minutes or so and stretch the other way.
  4. Think ergonomically. Design a workspace so it’s not necessary to hunch forward to see the computer monitor or reach way out for the mouse. Also, use a desk chair that supports posture.
  5.  Watch your posture. Don’t slump, be especially careful when lifting heavy objects and never bend over from the waist.
  6.  Wear low heels. High heels might create a more unstable posture and increase pressure on the lower spine.
  7.  Stop smoking. Smoking increases the risk of osteoporosis of the spine and other bone problems.
  8.  Watch weight. Use diet and exercise to keep weight within a healthy range for one’s height.

Unfortunately, following these tips doesn’t always bring relief, and many patients continue to suffer—to the point where potentially addictive prescription drugs become their only option.

That’s where BioDelivery Sciences International (BDSI), a Raleigh, NC-based specialty pharmaceutical company, is coming to the rescue with a new product to manage chronic pain disorders. One of BDSI’s late-stage investigational drugs is BEMA® Buprenorphine, a potent analgesic with a relatively long duration of action. In January, BDSI announced positive results from the first of two Phase 3 pivotal trials on opioid-naïve patients. The trial successfully met its primary goal, demonstrating significant improvement in chronic pain compared to placebo. Results from a second Phase 3 efficacy trial in opioid-experienced patients for the treatment of moderate-to-severe chronic low back pain, conducted by BDSI and its commercial partner Endo Pharmaceuticals, are expected in early July 2014. Should this trial be successful, an NDA for this product would be submitted to the FDA as early as January 2015.

Copyright-free content provided by DGIwire.